Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Oncology Pharmacy Practice is Scopus-indexed (Q3, CiteScore 2.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1078-1552Verify ISSN ↗1477-092XVerify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$4,150 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 167 / 278 | 40th | Q3 |
| Oncology | 272 / 428 | 36th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1995–present, best quartile Q3, CiteScore 2.7.
Journal of Oncology Pharmacy Practice is Q3 in Pharmacology (medical) (rank 167 of 278) and Q3 in Oncology (rank 272 of 428), by CiteScore 2025.
Journal of Oncology Pharmacy Practice is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q3 at the 40th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.426, quartile Q3, with an H-index of 50.
The publisher lists an article processing charge of about US$4,150 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Oncology Pharmacy Practice is published by SAGE Publications Ltd. Its print ISSN is 1078-1552 and its online ISSN is 1477-092X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Oncology Pharmacy Practice has an h-index of 56 and a 2-year mean of 1.02 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q3. On 2-year citations it ranks #179 of 271 Scopus journals in Pharmacology (medical).
Journal of Oncology Pharmacy Practice published 227 papers in 2025; its busiest recent year was 2020 with 379. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2026), authors are most often from United States (17.8%), India (12.2%) and China (5.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.